EUVIMEDEUVIMED entdecken
Crossref

HIV-1 infection converts CD4 + T cells to HLA class II–restricted CD8 + T cells

Jinfeng Cai iD, Wei Dong iD, Peipei Wang iD, Jiacong Zhao iD, Xinyu Liang iD, Zhuoyue Meng iD, Wei Wang iD, Jiasheng Zhou iD, Haixiang Peng iD, Huixin Wu iD, Shubin Chen iD, Jiazhen Chen iD und 9 weitere

Science Translational Medicine · 2026

DOI: 10.1126/scitranslmed.aec4912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Jinfeng Cai und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen Universit…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National key R&D program of China, Technology Projects of Guangdong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the primary receptor for HIV-1 entry, human CD4 is widely recognized as the hallmark of HIV-1 target cells. However, viral negative factor (Nef) and viral protein U (Vpu) down-regulate surface CD4 on infected cells, raising an intriguing question: If an infected CD4 + T cell survives and establishes latency, can CD4 expression recover? By tracking the fate of HIV-1–infected CD4 + T cells, we unexpectedly found that a subset of these cells directly convert to CD8 + T cells. T cell receptor (TCR) sequencing and single-cell RNA sequencing data revealed that these induced CD8 + T cells primarily originated from regulatory CD4 + T cells, which retained a regulatory-like phenotype postconversion. Mechanistically, HIV-1 viral protein R (Vpr) specifically induced this conversion by up-regulating transforming growth factor–β1 (TGF-β1), which, in turn, activates a TGF-β–dependent signaling pathway essential for CD8 lineage reprogramming. Critically, ex vivo analyses confirmed that CD8 + T cells from both untreated and antiretroviral therapy (ART)–suppressed people living with HIV-1 (PLWH) harbor transcriptionally active viral RNA or intact proviral DNA. Furthermore, we identified that human leukocyte antigen (HLA) class II–restricted CD8 + T cells, which were present in PLWH but absent in healthy controls, share TCR clonotypes with their antigen-specific CD4 + T cell counterparts, providing direct evidence for HIV-1–driven CD4-to-CD8 conversion in vivo. Collectively, these findings uncover a viral mechanism of host-cell reprogramming, demonstrate that CD8 + T cells constitute a previously overlooked component of the HIV-1 reservoir, and broaden our understanding of latent reservoir heterogeneity, an essential consideration for future cure strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesCD4-Positive T-LymphocytesHIV-1HIV InfectionsHistocompatibility Antigens Class IIHumansSignal TransductionReceptors, Antigen, T-CellTransforming Growth Factor beta1

Substanzen

Histocompatibility Antigens Class IIReceptors, Antigen, T-CellTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Genetics and Biomedical Informatics, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.
  • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Department of Infection and Immunology, Shenzhen Third People's Hospital, Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology, Shenzhen 518112, China.

ORCID-Profile: Jinfeng Cai, Wei Dong, Peipei Wang, Jiacong Zhao, Xinyu Liang, Zhuoyue Meng, Wei Wang, Jiasheng Zhou, Haixiang Peng, Huixin Wu, Shubin Chen, Jiazhen Chen, Hongbo Gao, Qiankun Wang, Haitao Zhang, Ting Huang, Lilin Wang, Zhanlian Huang, Liang Shan, Zhonghui Tang, Kai Deng

Förderung

  • National Natural Science Foundation of China
  • National key R&D program of China
  • Technology Projects of Guangdong Province of China
  • Prevention and Control of Emerging and Major Infectious Diseases National Science and Technology Major Project

Zitieren

APA

Cai, J., Dong, W., Wang, P., Zhao, J., Liang, X., Meng, Z., Wang, W., Zhou, J., Peng, H., Wu, H., Chen, S., Chen, J., Gao, H., Wang, Q., Zhang, H., Huang, T., Wang, L., Huang, Z., Shan, L., …, & Deng, K. (2026). HIV-1 infection converts CD4 + T cells to HLA class II–restricted CD8 + T cells. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aec4912

Vancouver

Cai J, Dong W, Wang P, Zhao J, Liang X, Meng Z, et al. HIV-1 infection converts CD4 + T cells to HLA class II–restricted CD8 + T cells. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aec4912

BibTeX
@article{Cai2026,
  author = {Cai, Jinfeng and Dong, Wei and Wang, Peipei and Zhao, Jiacong and Liang, Xinyu and Meng, Zhuoyue and Wang, Wei and Zhou, Jiasheng and Peng, Haixiang and Wu, Huixin and Chen, Shubin and Chen, Jiazhen and Gao, Hongbo and Wang, Qiankun and Zhang, Haitao and Huang, Ting and Wang, Lilin and Huang, Zhanlian and Shan, Liang and Tang, Zhonghui and Deng, Kai},
  title = {HIV-1 infection converts CD4 + T cells to HLA class II–restricted CD8 + T cells},
  journal = {Science Translational Medicine},
  year = {2026},
  doi = {10.1126/scitranslmed.aec4912}
}
Kostenlos starten →